The 10c rise was only on $150k. While not to be sneezed at it...

The 10c rise was only on $150k. While not to be sneezed at it can hardly be considered significant. Sadly I expect we will trickle back down again.

MSB is another example of the general apathy in the bio sector. They are doing good things, getting positive results, licencing products and are rated a buy or strong buy. Yet the SP is on the slide. Seems like you have to move the earth to get investment interest. The only thing I can think is the market is dominated by speculators and short term traders rather than investors. The news pipeline from Neuren is now largely known and some way off so the speculators have bailed. I don't hold much hope that a back ended ROW deal will cause much excitement either.

I still think we will end up with a deal with Acadia, but I doubt it will shoot the lights out on the up front.